GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Twinlab Consolidated Holdings Inc (OTCPK:TLCC) » Definitions » Sloan Ratio %

Twinlab Consolidated Holdings (Twinlab Consolidated Holdings) Sloan Ratio % : 0.00% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Twinlab Consolidated Holdings Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Twinlab Consolidated Holdings's Sloan Ratio for the quarter that ended in Mar. 2024 was 0.00%.

As of Mar. 2024, Twinlab Consolidated Holdings has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Twinlab Consolidated Holdings Sloan Ratio % Historical Data

The historical data trend for Twinlab Consolidated Holdings's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Twinlab Consolidated Holdings Sloan Ratio % Chart

Twinlab Consolidated Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -118.70 -26.61 -70.11 -18.22 -

Twinlab Consolidated Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Twinlab Consolidated Holdings's Sloan Ratio %

For the Packaged Foods subindustry, Twinlab Consolidated Holdings's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Twinlab Consolidated Holdings's Sloan Ratio % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Twinlab Consolidated Holdings's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Twinlab Consolidated Holdings's Sloan Ratio % falls into.



Twinlab Consolidated Holdings Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Twinlab Consolidated Holdings's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-13.714-2.897
-0)/8.995
=-184.67%

Twinlab Consolidated Holdings's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(-15-2.674
-0)/8.2
=-215.54%

Twinlab Consolidated Holdings's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was -3.991 (Jun. 2023 ) + -2.35 (Sep. 2023 ) + -6.563 (Dec. 2023 ) + -2.096 (Mar. 2024 ) = $-15.00 Mil.
Twinlab Consolidated Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was 0.766 (Jun. 2023 ) + 0.208 (Sep. 2023 ) + 1.68 (Dec. 2023 ) + 0.02 (Mar. 2024 ) = $2.67 Mil.
Twinlab Consolidated Holdings's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was 0 (Jun. 2023 ) + 0 (Sep. 2023 ) + 0 (Dec. 2023 ) + 0 (Mar. 2024 ) = $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Twinlab Consolidated Holdings  (OTCPK:TLCC) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, Twinlab Consolidated Holdings has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Twinlab Consolidated Holdings Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Twinlab Consolidated Holdings's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Twinlab Consolidated Holdings (Twinlab Consolidated Holdings) Business Description

Traded in Other Exchanges
N/A
Address
4800 T-Rex Avenue, Suite 225, Boca Raton, FL, USA, 33431
Twinlab Consolidated Holdings Inc, along with its subsidiaries, is engaged in the manufacturing and distribution of nutritional supplements and other natural products. It offers a wide range of products such as vitamins, minerals, specialty supplements and sports nutrition products. It also manufactures and sells diet and energy products. The company markets its products under five primary brand names: Twinlab (vitamins and minerals), Twinlab Fuel, MetaboLife, Trigosamine and Alvita Teas. Twinlab sold its products primarily through health and natural food stores and national and regional drug store chains, supermarkets, and mass-market retailers.
Executives
Kyle Casey officer: Interim CFO C/O TWINLAB CONSOLIDATED HOLDINGS, INC., 4800 T-REX AVENUE, SUITE 305, BOCA RATON FL 33431
Carla Goffstein officer: CFO (Interim) C/O TWINLAB CONSOLIDATED HOLDINGS, INC., 4800 T-REX AVENUE, #305, BOCA RATON FL 33431
Brent Baker officer: President - Sports Nutrition 4800 T-REX AVE, SUITE 305, BOCA RATON FL 33431
Alan S Gever officer: CFO & COO 115 WEST CENTURY ROAD, SUITE 260, PARAMUS NJ 07652
Mary Marbach officer: Chief Legal Officer 5400 BROKEN SOUND BLVD., NW - SUITE 500, BOCA RATON FL 33487
David A Still director C/O FISHER ASSET MANAGEMENT LLC, ONE FISHERS ROAD, PITTSFORD NY 14534
Naomi Whittel director, officer: Chief Executive Officer C/O STAR SCIENTIFIC, INC., 4470 COX ROAD, SUITE 110, GLEN ALLEN VA 23060
Mark Bugge director 10753 MACATAWA DRIVE, HOLLAND MI 49424
Ralph Iannelli director 1486 EAST VALLEY ROAD, SANTA BARBARA CA 93108
William Eric Stevens officer: Chief Financial Officer C/O RESERVEAGE, ONE BOCA PLACE, 2255 GLADES ROAD, BOCA RATON FL 33431
Golisano Holdings Llc 10 percent owner 1 FISHERS ROAD, PITTSFORD NY 14534
B Thomas Golisano 10 percent owner
Great Harbor Capital, Llc 10 percent owner 3133 ORCHARD VISTA DRIVE SE, GRAND RAPIDS MI 49546
Mark Andrew Walsh officer: See Remarks TWINLAB CONSOLIDATED HOLDINGS, INC., 632 BROADWAY SUITE 201, NEW YORK NY 10012
Seth Ellis director PENTA MEZZANINE FUND, 20 N. ORANGE AVENUE, ORLANDO FL 32801

Twinlab Consolidated Holdings (Twinlab Consolidated Holdings) Headlines